§ That this House takes note of European Union Document No. 10122/03, amended draft Directive on setting standards of quality and safety for the donation, procurement, testing, processing, storage and distribution of human tissues and cells; notes the additional set-up costs and annual running costs arising in the United Kingdom are now expected to be greater than originally anticipated, and in particular may require investment by fertility clinics to upgrade their facilities and practices, but recognises that these costs will be offset by significant benefits to patients, and 745 therefore supports the Government's position that the proposed Directive, as presently drafted, is broadly acceptable.—[Mr. Ainger.]
§ Question agreed to.